retrovirology.com Report : Visit Site

Technical data of the retrovirology.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host retrovirology.com. Currently, hosted in United States and its service provider is Tiggee LLC .

aidsmap.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Oscar Platform 201802052158-287 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

skip to content advertisement menu explore journals get published about bmc login my account search search all bmc articles search retrovirology menu home about articles collections submission guidelines search submit a manuscript featured collections broadly neutralizing antibodies (bnabs) against hiv a review series on bnab development after hiv-1 infection, the application of bnabs as therapeutics and the attempts to elicit bnabs by vaccination. edited by rogier sanders and marit van gils. measuring hiv-1 persistence in vivo a collection of review articles describing traditional and novel methods of quantitation of hiv persistence in vivo. edited by ben berkhout and alexander pasternak the kt jeang retrovirology prize 2018 retrovirology awards the annual kt jeang retrovirology prize to recognize outstanding achievements in the field by mid-career scientists. it is with great pleasure that we announce the 2018 winner: eric freed . an editorial briefly outlining the winner's achievements has been published here . past winners are: s. goff (2005), j. sodroski (2006), k. beemon (2007), b. berkhout (2008), t. heidman (2009), m. malim (2010), m. matsuoka (2011), m. benkirane (2013), p. bieniasz (2015), f. kirchhoff (2016), and m. emerman (2017). articles recent most accessed content type: research | 27 november 2018 mbl2 gene polymorphisms in hhv-8 infection in people living with hiv/aids authors: viviane martha santos de morais, elker lene santos de lima, georgea gertrudes de oliveira mendes cahú, thaisa regina rocha lopes, juliana prado gonçales, maria tereza cartaxo muniz and maria rosângela cunha duarte coêlho content type: review | 26 november 2018 hiv-1 immunogens and strategies to drive antibody responses towards neutralization breadth authors: jelle van schooten and marit j. van gils content type: review | 16 november 2018 antibody-mediated prevention and treatment of hiv-1 infection authors: henning gruell and florian klein content type: research | 6 november 2018 distinct gene expression signatures induced by viral transactivators of different htlv-1 subgroups that confer a different risk of ham/tsp authors: tadasuke naito, jun-ichirou yasunaga, yuichi mitobe, kazumasa shirai, hiroe sejima, hiroshi ushirogawa, yuetsu tanaka, tatsufumi nakamura, kousuke hanada, masahiro fujii, masao matsuoka and mineki saito content type: review | 23 october 2018 the role of integration and clonal expansion in hiv infection: live long and prosper authors: elizabeth m. anderson and frank maldarelli most recent articles rss view all articles content type: review | 7 september 2012 can immunotherapy be useful as a “functional cure” for infection with human immunodeficiency virus-1? authors: guido vanham and ellen van gulck content type: research | 14 april 2016 combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory t cells enhances anti-viral immunity during chronic retroviral infection authors: torben knuschke, olga rotan, wibke bayer, viktoriya sokolova, wiebke hansen, tim sparwasser, ulf dittmer, matthias epple, jan buer and astrid m. westendorf content type: review | 26 june 2013 hiv-1 transcription and latency: an update authors: carine van lint, sophie bouchat and alessandro marcello content type: research | 17 december 2013 differential inhibition of line1 and line2 retrotransposition by vertebrate aid/apobec proteins authors: nataša lindič, maruška budič, toni petan, binyamin a knisbacher, erez y levanon and nika lovšin content type: short report | 29 may 2013 a novel acute hiv infection staging system based on 4 th generation immunoassay authors: jintanat ananworanich, james lk fletcher, suteeraporn pinyakorn, frits van griensven, claire vandergeeten, alexandra schuetz, tippawan pankam, rapee trichavaroj, siriwat akapirat, nitiya chomchey, praphan phanuphak, nicolas chomont, nelson l michael, jerome h kim and mark de souza most accessed articles rss view all articles journal news stay up-to-date with the latest news and announcements from the editors of retrovirology . read more editors-in-chief andrew lever, university of cambridge, uk johnson mak, institute for glycomics, griffith university, australia founding editor kuan-teh jeang, national institutes of health, usa aims and scope retrovirology is an open access, online journal that publishes stringently peer-reviewed, high-impact articles on host-pathogen interactions, fundamental mechanisms of replication, immune defenses, animal models, and clinical science relating to retroviruses. retroviruses are pleiotropically found in animals. well-described examples include avian, murine and primate retroviruses. two human retroviruses are especially important pathogens. these are the human immunodeficiency virus, hiv, and the human t-cell leukemia virus, htlv. hiv causes aids while htlv-1 is the etiological agent for adult t-cell leukemia and htlv-1-associated myelopathy/tropical spastic paraparesis. retrovirology aims to cover comprehensively all aspects of human and animal retrovirus research. latest tweets editor profiles andrew lever, editor-in- chief professor lever graduated in biochemistry and medicine from the university of wales and undertook postgraduate training in clinical medicine there and in london and newcastle. he took a doctorate in immunology studying patients with immunodeficiency at the mrc clinical research centre in london and further developed his interests in the balance between infectious agents and the immune system with a lectureship funded by the wellcome trust at the royal free hospital in london studying viral hepatitis and cytomegalovirus infection. his research on hiv began in boston with dr joe sodroski where he began work on studying the mechanism of rna encapsidation of retroviruses. he returned to a senior lecturer post at st george’s hospital, london and moved subsequently to the university of cambridge, where he was awarded a personal chair in infectious diseases in 2000. his research on retroviruses involves studies of the biology and fate of the genomic rna in lentiviruses and allied work on lentivirus-based vectors and hiv latency, subjects which are core to retrovirology. johnson mak, editor-in-chief professor mak is a native of hong kong who undertook his undergraduate and post-graduate training at mcgill university in montreal, canada. during his phd johnson worked with professor lawrence kleiman at the mcgill aids centre studying packaging of primer trna into hiv. he subsequently moved to melbourne, australia to continue work on hiv assembly at the burnet institute under the guidance of professor suzanne crowe. he is currently a professor at the institute for glycomics, griffith university, gold coast. he has a broad research portfolio in hiv having studied primer trnas in retroviruses, genomic rna packaging and dimerization, cholesterol and lipids in hiv, viral-host interactions, imaging of hiv and analysis of recombination and mutation in hiv using next generation sequencing. his team pioneered the production of full-length recombinant hiv gag for biochemical and biophysical analyses of hiv assembly. recently johnson and his team have described a pre-entry priming process for hiv. advertisement submit a manuscript editorial board sign up for article alerts and news from this journal follow follow us on twitter 2017 journal metrics speed 39 days to first decision for reviewed manuscripts only 39 days to first decision for all manuscripts 91 days from submission to acceptance 13 days from acceptance to publication citation impact 3.417 - 2-year impact factor 3.478 - 5-year impact factor 0.812 - source normalized impact per paper (snip) 1.855 - scimago journal rank (sjr) usage 779,175 downloads 316 mentions more about our metrics advertisement retrovirology issn: 1742-4690 contact us submission enquiries: access here and click contact us general enquiries: [email protected] explore journals get published about bmc re

URL analysis for retrovirology.com

https://retrovirology.biomedcentral.com/articles/most-accessed/rss.xml
https://retrovirology.biomedcentral.com/articles/most-recent/rss.xml
https://retrovirology.biomedcentral.com/articles/10.1186/s12977-018-0454-x
https://retrovirology.biomedcentral.com/submission-guidelines
https://retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-156
https://retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-67
https://retrovirology.biomedcentral.com/about
https://retrovirology.biomedcentral.com/articles/collections
https://retrovirology.biomedcentral.com/articles
https://retrovirology.biomedcentral.com/articles/10.1186/s12977-018-0430-5
https://retrovirology.biomedcentral.com/articles/10.1186/1742-4690-9-72
https://retrovirology.biomedcentral.com/#tab-1
https://retrovirology.biomedcentral.com/#tab-2
https://retrovirology.biomedcentral.com/articles/10.1186/s12977-018-0455-9
https://retrovirology.biomedcentral.com/articles/10.1186/s12977-016-0258-9

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: RETROVIROLOGY.COM
Registry Domain ID: 106522305_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.eurodns.com
Registrar URL: http://www.EuroDNS.com
Updated Date: 2017-11-06T04:01:57Z
Creation Date: 2003-11-12T14:59:44Z
Registry Expiry Date: 2018-11-12T14:59:44Z
Registrar: EuroDNS S.A
Registrar IANA ID: 1052
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +352.27220150
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS10.DNSMADEEASY.COM
Name Server: NS11.DNSMADEEASY.COM
Name Server: NS12.DNSMADEEASY.COM
Name Server: NS13.DNSMADEEASY.COM
Name Server: NS14.DNSMADEEASY.COM
Name Server: NS15.DNSMADEEASY.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-25T01:03:56Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR EuroDNS S.A

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =retrovirology.com

  PORT 43

  TYPE domain

DOMAIN

  NAME retrovirology.com

  CHANGED 2017-11-06

  CREATED 2003-11-12

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS10.DNSMADEEASY.COM 208.94.148.4

  NS11.DNSMADEEASY.COM 208.80.124.4

  NS12.DNSMADEEASY.COM 208.80.126.4

  NS13.DNSMADEEASY.COM 208.80.125.4

  NS14.DNSMADEEASY.COM 208.80.127.4

  NS15.DNSMADEEASY.COM 208.94.149.4

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .